Ligand-activated liver X receptor α (LXRα) upregulates the expression of hepatic lipogenic genes, which leads to triglyceride (TG) accumulation, resulting in nonalcoholic fatty liver disease (NAFLD). The gene discussed is NR1H3; the disease is metabolic dysfunction-associated steatotic liver disease.